<DOC>
	<DOCNO>NCT00748813</DOCNO>
	<brief_summary>Annual trial registration influenza vaccine strain composition season 2008/2009</brief_summary>
	<brief_title>Safety Immunogenicity Surface Antigen , Inactivated , Influenza Vaccine Using Strain Composition 2008/2009</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects eligible enrollment study male female adult : 1 . â‰¥ 18 year age , mentally competent , willing able give inform consent prior study entry 2. able comply study requirement 3. good health determine : medical history physical examination clinical judgment investigator They serious chronic acute disease ( judgment investigator ) include limit : 1 . Cancer , except localize skin cancer ; 2 . Advanced congestive heart failure ; 3 . Chronic obstructive pulmonary disease ( COPD ) ; 4 . Autoimmune disease ( include rheumatoid arthritis ) ; 5 . Acute progressive hepatic disease ; 6 . Acute progressive renal disease ; 7 . Severe neurological psychiatric disorder ; 8 . Severe asthma . They history anaphylactic reaction and/or serious allergic reaction follow vaccination , proven hypersensitivity component study vaccine ( e.g. , ovalbumin , chicken protein , chicken feather , influenza viral protein , kanamycin neomycin sulphate ) ; They know suspect ( high risk develop ) impairment/alteration immune function ( exclude normally associate advanced age ) resulting , example , : receipt immunosuppressive therapy ( parenteral oral corticosteroid cancer chemotherapy/radiotherapy ) within past 60 day full length study ; receipt immunostimulants ; receipt parenteral immunoglobulin preparation , blood product and/or plasma derivates within past 3 month full length study ; suspect know HIV infection HIVrelated disease ; They know suspected history drug alcohol abuse ; They bleed diathesis condition associate prolonged bleeding time investigator 's opinion would interfere safety subject ; Women pregnant , woman able bear child willing practice acceptable contraception duration trial ( 21 day ) ; Within past 12 month , : receive one injection influenza vaccine Within past 6 month , : laboratory confirm influenza disease ; receive influenza vaccine ; Within past 4 week receive : another vaccine ; investigational agent ; They acute chronic infection require systemic antibiotic treatment antiviral therapy within last 7 day ; 1 They experience acute exacerbation COPD within past 14 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Influenza vaccine</keyword>
</DOC>